Castellanos, G.; Pardo, L.; López, A.; Cornago, J.; López, J.L.; de las Heras, A.; DÃaz, F.J.; MartÃnez de Bourio, M.; Castillo, E.; Llamas, P.;
et al. Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Biomedicines 2024, 12, 512.
https://doi.org/10.3390/biomedicines12030512
AMA Style
Castellanos G, Pardo L, López A, Cornago J, López JL, de las Heras A, DÃaz FJ, MartÃnez de Bourio M, Castillo E, Llamas P,
et al. Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Biomedicines. 2024; 12(3):512.
https://doi.org/10.3390/biomedicines12030512
Chicago/Turabian Style
Castellanos, Gonzalo, Laura Pardo, Alberto López, Javier Cornago, Jose Luis López, Alicia de las Heras, Francisco J. DÃaz, Marta MartÃnez de Bourio, Eva Castillo, Pilar Llamas,
and et al. 2024. "Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report" Biomedicines 12, no. 3: 512.
https://doi.org/10.3390/biomedicines12030512
APA Style
Castellanos, G., Pardo, L., López, A., Cornago, J., López, J. L., de las Heras, A., DÃaz, F. J., MartÃnez de Bourio, M., Castillo, E., Llamas, P., & Solán, L.
(2024). Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Biomedicines, 12(3), 512.
https://doi.org/10.3390/biomedicines12030512